{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:00:20Z","timestamp":1793322020111,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacc.2024.06.023","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:03:47Z","timestamp":1725271427000},"page":"1025-1037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Competing Risks in Clinical Trials"],"prefix":"10.1016","volume":"84","author":[{"given":"John","family":"Gregson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.06.023_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.2008.294","article-title":"The analysis of survival data in nephrology: basic concepts and methods of Cox regression","volume":"74","author":"van Dijk","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2024.06.023_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2024.06.023_bib3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2024.06.023_bib4","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1002\/sim.6274","article-title":"Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation","volume":"33","author":"Jackson","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib5","author":"Ruau"},{"key":"10.1016\/j.jacc.2024.06.023_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib8","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/biostatistics\/kxl043","article-title":"Joint frailty models for recurring events and death using maximum penalized likelihood estimation: Application on cancer events","volume":"8","author":"Rondeau","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jacc.2024.06.023_bib10","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"10.1016\/j.jacc.2024.06.023_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2213-2600(22)00412-X","article-title":"Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care","volume":"11","author":"Shah","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2023.07.024","article-title":"Recurrent events in cardiovascular trials: JACC State-of-the-Art Review","volume":"82","author":"Gregson","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.06.023_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.0006-341X.2002.00510.x","article-title":"A\u00a0frailty model for informative censoring","volume":"58","author":"Huang","year":"2002","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2024.06.023_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/biomet\/89.3.617","article-title":"Estimation of the failure time distribution in the presence of informative censoring","volume":"89","author":"Scharfstein","year":"2002","journal-title":"Biometrika"},{"key":"10.1016\/j.jacc.2024.06.023_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/10543406.2013.860769","article-title":"A\u00a0Multiple Imputation Method for Sensitivity Analyses of Time-to-Event Data with Possibly Informative Censoring","volume":"24","author":"Zhao","year":"2014","journal-title":"J\u00a0Biopharm Stat"},{"key":"10.1016\/j.jacc.2024.06.023_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/19466315.2023.2182355","article-title":"Methods for Informative Censoring in Time-to-Event Data Analysis","volume":"16","author":"Jin","year":"2024","journal-title":"Stat Biopharm Res"},{"key":"10.1016\/j.jacc.2024.06.023_bib18","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular imaging-guided or angiography-guided complex pci","volume":"388","author":"Lee","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMoa2200963","article-title":"CT or invasive coronary angiography in stable chest pain","volume":"386","author":"Maurovich-Horvat","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib24","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","article-title":"The use and interpretation of competing risks regression models","volume":"18","author":"Dignam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jacc.2024.06.023_bib25","author":"Allison"},{"key":"10.1016\/j.jacc.2024.06.023_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jchf.2022.02.007","article-title":"Covariate adjustment in cardiovascular randomized controlled trials: its value, current practice, and need for improvement","volume":"10","author":"Pirondini","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2024.06.023_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaccao.2022.08.002","article-title":"Considerations of competing risks analysis in cardio-oncology studies: JACC: Cardiooncology state-of-the-art review","volume":"4","author":"Li","year":"2022","journal-title":"JACC CardioOncology"},{"key":"10.1016\/j.jacc.2024.06.023_bib28","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ejhf.2607","article-title":"Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","volume":"24","author":"Pocock","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2024.06.023_bib29","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/sim.7800","article-title":"Dealing with competing risks in clinical trials: How to choose the primary efficacy analysis?","volume":"37","author":"Troendle","year":"2018","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/sim.2054","article-title":"Testing treatment effects in the presence of competing risks","volume":"24","author":"Freidlin","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2024.06.023_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6215-9-30","article-title":"Competing risk and heterogeneity of treatment effect in clinical trials","volume":"9","author":"Kent","year":"2008","journal-title":"Trials"},{"key":"10.1016\/j.jacc.2024.06.023_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pst.200","article-title":"Power and sample size considerations in clinical trials with competing risk endpoints","volume":"5","author":"Maki","year":"2006","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jacc.2024.06.023_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2016.12.001","article-title":"Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations","volume":"82","author":"Manja","year":"2017","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jacc.2024.06.023_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724077465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724077465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:58:14Z","timestamp":1757512694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724077465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0735109724077465"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.06.023","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Competing Risks in Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}